Financial investors Advent International and Carlyle Group have acquired H C Starck from German chemicals and pharmaceuticals group Bayer for EUR 1.2bn. Swiss bank UBS ran the limited auction process, which had attracted trade as well as financial buyers. The enterprise value consists of EUR 700m net equity value plus EUR 450m of net financial liabilities.
Sale of the drive technology unit saw interest from sponsors including CVC, Triton and Brookfield
AUM bump driven by commitments to CapMan Nordic Real Estate III and CapMan Growth II funds
This round is an extension to an €11m series-B investment raised by the company in July 2019
Elevat3 Capital and German energy group EWE also back the green project-financing platform